[Zinc concentration in serum and saliva of patients during heavy metal chelating therapy].
D002614:Chelating Agents / Q000627:therapeutic use*; D003300:Copper / Q000097:blood; D003676:Deferoxamine / Q000627:therapeutic use; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D007501:Iron / Q000097:blood; D007978:Levamisole / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D012463:Saliva / Q000032:analysis*; D008625:Tiopronin / Q000627:therapeutic use; D015032:Zinc / Q000032:analysis* / Q000097:blood
D002614:Chelating Agents; D007978:Levamisole; D003300:Copper; D008625:Tiopronin; D007501:Iron; D010396:Penicillamine; D003676:Deferoxamine; D015032:Zinc
Zinkkonzentrationen im Serum und Speichel von Patienten unter Schwermetall-Chelatator-Therapie.